207 related articles for article (PubMed ID: 34896523)
21. Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma.
Hu K; Yao L; Zhou L; Li J
Int J Gen Med; 2022; 15():2463-2474. PubMed ID: 35282653
[TBL] [Abstract][Full Text] [Related]
22. Expression and prognostic value of Chromobox family members in gastric cancer.
Ma T; Ma N; Chen JL; Tang FX; Zong Z; Yu ZM; Chen S; Zhou TC
J Gastrointest Oncol; 2020 Oct; 11(5):983-998. PubMed ID: 33209492
[TBL] [Abstract][Full Text] [Related]
23. Diverse CBX family members as potential prognostic biomarkers in non-small-cell lung cancer.
Xie X; Ning Y; Long J; Wang H; Chen X
FEBS Open Bio; 2020 Oct; 10(10):2206-2215. PubMed ID: 32894652
[TBL] [Abstract][Full Text] [Related]
24. Expression and Prognostic Value of Chromobox Family Proteins in Esophageal Cancer.
Liu J; Shen H; Chen X; Ding Y; Wang H; Xu N; Teng L
Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140750
[TBL] [Abstract][Full Text] [Related]
25. Methylation silencing CDH23 is a poor prognostic marker in diffuse large B-cell lymphoma.
Cao B; Guo X; Huang L; Wang B; Wang W; Han D; Zhang W; Zhong K
Aging (Albany NY); 2021 Jul; 13(13):17768-17788. PubMed ID: 34252883
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of distinct CBX family members in breast cancer.
Liang YK; Lin HY; Chen CF; Zeng D
Oncotarget; 2017 Nov; 8(54):92375-92387. PubMed ID: 29190923
[TBL] [Abstract][Full Text] [Related]
27. Chromobox Family Proteins as Putative Biomarkers for Breast Cancer Management: A Preliminary Study Based on Bioinformatics Analysis and qRT-PCR Validation.
Tian H; Zhao T; Li Y; Sun N; Ma D; Shi Q; Zhang G; Chen Q; Zhang K; Chen C; Zhang Y; Qi X
Breast Cancer (Dove Med Press); 2022; 14():515-535. PubMed ID: 36605919
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of CBX2 in colorectal cancer: database mining for CBX family members in malignancies and vitro analyses.
Zhou H; Xiong Y; Liu Z; Hou S; Zhou T
Cancer Cell Int; 2021 Jul; 21(1):402. PubMed ID: 34321009
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of the prognosis for chromobox family in gastric cancer.
Lin K; Zhu J; Hu C; Bu F; Luo C; Zhu X; Zhu Z
J Gastrointest Oncol; 2020 Oct; 11(5):932-951. PubMed ID: 33209489
[TBL] [Abstract][Full Text] [Related]
30. Identifying
Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
PeerJ; 2023; 11():e16618. PubMed ID: 38099311
[TBL] [Abstract][Full Text] [Related]
31. Expression Patterns and Prognostic Values of ORMDL1 in Different Cancers.
Zhu T; Chen Y; Min S; Li F; Tian Y
Biomed Res Int; 2020; 2020():5178397. PubMed ID: 33145351
[TBL] [Abstract][Full Text] [Related]
32. Pan-cancer analysis of Chromobox (CBX) genes for prognostic significance and cancer classification.
Naqvi AAT; Rizvi SAM; Hassan MI
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166561. PubMed ID: 36183965
[TBL] [Abstract][Full Text] [Related]
33. CBX Family Members in Two Major Subtypes of Renal Cell Carcinoma: A Comparative Bioinformatic Analysis.
Grimaldi AM; Affinito O; Salvatore M; Franzese M
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292141
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis reveals the value of the expression of chromobox family members for bladder urothelial carcinoma prognosis.
Meng X; Cao R; Liu X; Fu B; Luo L; Jiang M; Wang K; Liu Y; Zhu Q; Yang C; Zhou L
Oncol Lett; 2023 Apr; 25(4):172. PubMed ID: 36970607
[TBL] [Abstract][Full Text] [Related]
35. Biological functions of chromobox (CBX) proteins in stem cell self-renewal, lineage-commitment, cancer and development.
van Wijnen AJ; Bagheri L; Badreldin AA; Larson AN; Dudakovic A; Thaler R; Paradise CR; Wu Z
Bone; 2021 Feb; 143():115659. PubMed ID: 32979540
[TBL] [Abstract][Full Text] [Related]
36. Genome-wide identification, evolution of chromobox family genes and their expression in Nile tilapia.
Liu XY; Zhang XB; Li MH; Zheng SQ; Liu ZL; Cheng YY; Wang DS
Comp Biochem Physiol B Biochem Mol Biol; 2017 Jan; 203():25-34. PubMed ID: 27614332
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma.
Nan YY; Zhang WJ; Huang DH; Li QY; Shi Y; Yang T; Liang XP; Xiao CY; Guo BL; Xiang Y
World J Clin Cases; 2021 Jun; 9(18):4585-4598. PubMed ID: 34222425
[TBL] [Abstract][Full Text] [Related]
38. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
Zheng W; Lin Q; Issah MA; Liao Z; Shen J
BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma.
Zhou X; Guo S; Shi Y
Sci Rep; 2022 Feb; 12(1):2817. PubMed ID: 35181719
[TBL] [Abstract][Full Text] [Related]
40. OSdlbcl: An online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma.
Dong H; Wang Q; Zhang G; Li N; Yang M; An Y; Xie L; Li H; Zhang L; Zhu W; Zhao S; Zhang H; Guo X
Cancer Med; 2020 Mar; 9(5):1790-1797. PubMed ID: 31918459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
